Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114659) titled 'Torametinib for the Treatment of Recurrent/Refractory Pediatric Tumors' on Dec. 16, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital,Sun Yat-sen University
Condition:
MAPK pathway related childhood tumors
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-20
Target Sample Size: Test group:28;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299400
Published by HT Digital Content Services with permission from Health Daily Digest....